Clinical Trials

Our physicians at Retina Specialists are nationally recognized and actively involved in multi-centered clinical trials on novel therapeutic approaches to vitreoretinal diseases. Our research team is committed to carefully selecting well-designed, safe clinical studies that offer promising and exciting new treatments for our patients. Our clinical trials are a valuable opportunity for patients to access novel treatments for Vitreoretinal diseases.

We participate in numerous active national eye research studies, including:

Diabetic Retinopathy:

BOULEVARD (Protocol BP30099): A Phase II Study of RO6867461 in Participants With Center-Involving Diabetic Macular Edema (CI-DME)

  • Principal Investigator: Robert E. Torti, MD
  • Sponsor: Hoffmann-La Roche
  • Study Coordinator: Debbie Bolling (dbolling@retinaspecialists.com)
  • Status: Recruiting

Age-Related Macular Degeneration:

GX29455 EXPOSURE RESPONSE: Phase II Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

  • Principal Investigator: Robert E. Torti, MD
  • Sponsor: Genentech, Inc.
  • Study Coordinator: Debbie Bolling (dbolling@retinaspecialists.com)
  • Status: Recruiting

FOVISTA (OPH1004): A Phase III study to evaluate the safety and efficacy of intravitreal administration of Fovista® administered in combination with either Bevacizumab or Aflibercept compared to Bevacizumab or Aflibercept monotherapy

  • Principal Investigator: Santosh C. Patel, MD
  • Sponsor: Ophthotech Corporation
  • Study Coordinator: Debbie Bolling (dbolling@retinaspecialists.com)
  • Status: Active, not recruiting

HAWK STUDY (RTH258-C001): A Phase III Study comparing the Efficacy and Safety of RTH258 Versus Aflibercept

  • Principal Investigator: Santosh C. Patel, MD
  • Sponsor: Alcon Research
  • Study Coordinator: Debbie Bolling (dbolling@retinaspecialists.com)
  • Status: Active, not recruiting
For more information or to refer a patient for evaluation, please contact our Clinical Trials Coordinator:

Debbie Bolling

972-599-9098
dbolling@retinaspecialists.net